Home > Insider Trading > Filing (0001178913-23-003971)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1638097	Entera Bio Ltd.	ENTX	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1686530	Jayne Miranda Toledano	Kiryat Hadassah, Minrav Building, 5Th Floor Jerusalem L3 9112002	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares, Par Value Nis 0.0000769 Per Share	Acquisiton	2023-12-22	23,952	$0.71	110,752	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares, Par Value Nis 0.0000769 Per Share	Warrants (right to buy)	Acquisiton	2023-12-22	23,952	$0.13	23,952	$1.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
23,952	2023-12-22	2028-12-22	No	4	P	Direct

Footnotes

The Reporting Person entered into a Securities Purchase Agreement with the Issuer on December 20, 2023, pursuant to which, on December 22, 2023, the Reporting Person acquired an aggregate of 23,952 units for a purchase price of $0.835 per unit, each unit consisting of one share of the Issuer's ordinary shares, par value NIS 0.0000769 per share ("Ordinary Shares"), and one warrant, exercisable to purchase an Ordinary Share at an exercise price of $1.00 per share. The purchase price for each unit included $0.125 for the warrant in accordance with Nasdaq rules.